Quad Technologies

Biopharma, Biotechnology, Clinical Trials, Information Technology
Founded in 2013-01-01
Woburn, Massachusetts, United States
http://quadtechnologies.com/
For Profit

About Quad Technologies

Quad Technologies is disrupting cell separation and cell therapy workflows by providing researchers with a simple, cell-friendly capture and release technology for cell isolation. Their new MagCloudz™ Streptavidin Cell Separation kit, featuring novel QuickGel™ technology platform, enables straightforward, scalable and fast cell separation with unique magnetic particle dissociation, resulting in complete label free cells. For applications such as T Cell purification, stem cell isolation, circulating tumor cell (CTC) separation and immunotherapy, this unique solution offers drastically improved cell viability, purity and recovery while maintaining a native cellular phenotype.

Company Metrics

  • Employees: 11-50
  • Monthly Visits: None
  • Tech Stack: 13 active products

Financial Information

  • Estimated Revenue: $1M to $10M
  • Total Funding: 3010000 USD
  • Last Funding: None (Convertible Note)
  • Funding Status: M&A

Technology Stack

Quad Technologies actively uses 13 products in their tech stack.

Market Presence

Industries: Biopharma, Biotechnology, Clinical Trials, Information Technology

Headquarters: Woburn, Massachusetts, United States